fda bpc-157 warning unapproved new drug FDA Moves to Reevaluate Several Peptides Is BPC-157 Banned? Oral vs.
Description
Technically yes, but the risk profile changes significantly
Once opened, mark the date on the vial and discard after 28 days regardless of appearance
This might be one of the best arguments as to why there needs to be more human trials
The same principles apply to tirzepatide and retatrutide, though specific guidelines for retatrutide will not exist until it reaches the market
